Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $20,536 | $18,324 | $19,965 | $22,280 |
| - Cash | $3,863 | $2,759 | $2,598 | $2,375 |
| + Debt | $6,590 | $6,595 | $6,621 | $6,630 |
| Enterprise Value | $23,263 | $22,159 | $23,988 | $26,536 |
| Revenue | $2,455 | $2,646 | $2,431 | $2,455 |
| % Growth | -7.2% | 8.8% | -1% | – |
| Gross Profit | $1,578 | $1,699 | $1,853 | $1,871 |
| % Margin | 64.3% | 64.2% | 76.2% | 76.2% |
| EBITDA | $827 | $1,110 | $865 | $692 |
| % Margin | 33.7% | 42% | 35.6% | 28.2% |
| Net Income | $467 | $635 | $241 | $267 |
| % Margin | 19% | 24% | 9.9% | 10.9% |
| EPS Diluted | 3.17 | 4.35 | 1.64 | 1.83 |
| % Growth | -27.1% | 165.2% | -10.4% | – |
| Operating Cash Flow | $1,273 | $161 | $259 | $761 |
| Capital Expenditures | -$46 | -$17 | -$47 | -$66 |
| Free Cash Flow | $1,226 | $144 | $212 | $695 |